Autologous Cell Therapy for Urinary Incontinence
Urinary Incontinence
Clinical DevelopmentActive
Key Facts
About Innovacell Biotechnologie
A regenerative medicine company developing autologous cell therapies for fecal and urinary incontinence.
View full company profileTherapeutic Areas
Other Urinary Incontinence Drugs
| Drug | Company | Phase |
|---|---|---|
| Mirabegron Intermediate | AR Life Science | Commercial |
| MicroPort® UniFlow Streamliner™ Implantable Tibial Nerve Stimulator | MicroPort | Regulatory Review (NMPA Green Path) |